Abstract-The relation between left ventricular hypertrophy (LVH) and unfavorable cardiovascular prognosis may involve systemic inflammation and endothelial dysfunction/damage. The aim of this study was to investigate in a cross-sectional design the relationships of LVH with C-reactive protein (CRP) levels (a marker of systemic low-grade inflammation) and with microalbuminuria (a marker of glomerular endothelial damage) in 705 patients with resistant hypertension. At baseline, all were submitted to a laboratory evaluation including 24-hour urinary albumin excretion, 2D echocardiogram, and 24-hour ambulatory blood pressure monitoring. A total of 463 patients also had high-sensitivity CRP levels determined. LVH was defined as an indexed left ventricular mass Ͼ110 g/m 2 in women and Ͼ125 g/m 2 in men. Microalbuminuria was evaluated in 3 categories: low normal (Ͻ15 mg/24 hours), high normal (between 15 and 29 mg/24 hours), and abnormal (between 30 and 299 mg/24 hours). CRP was dichotomized at the median value (3.7 mg/L). Associations with LVH were examined after adjustment for all of the potential confounders by multivariate logistic regression. A total of 534 patients (75.7%) had LVH. After full adjustment, both abnormal microalbuminuria (odds ratio: 1.97; 95% CI: 1.04 to 3.73) and high CRP (OR: 1.76; 95% CI: 1.06 to 2.93) were independently associated with LVH occurrence. The high-normal albuminuria was associated with a borderline significant 46% increased chance of having LVH. Furthermore, the association between high CRP and LVH was observed exclusively in the subgroup with normal albuminuria. In conclusion, both systemic inflammation and endothelial damage were associated with LVH occurrence. These relationships offer insight into the pathophysiological mechanisms linking LVH to atherosclerosis and to increased cardiovascular morbidity and mortality. Key Words: cardiovascular risk Ⅲ C-reactive protein Ⅲ left ventricular hypertrophy Ⅲ microalbuminuria L eft ventricular hypertrophy (LVH) is a hypertensive target organ damage strongly predictive of future cardiovascular morbidity and mortality. 1 However, the pathophysiologic mechanisms underlying the evolution from LVH to cardiovascular event development are still unclear, but they may involve accelerated atherosclerosis 2 because of systemic inflammation and endothelial dysfunction. 3 C-reactive protein (CRP), a marker of chronic low-grade systemic inflammation, is a predictor of untoward cardiovascular prognosis, beyond traditional risk factors, in different populations. 4 Also, its levels are generally elevated in patients with hypertension, 5 and high CRP may even precede and predict the development of arterial hypertension. 6 Similarly, microalbuminuria (MA), a slight elevation of urinary albumin excretion rate (UAER), reflects endothelial dysfunction/damage at the glomerulus and possibly also systemically 7 and is a risk marker for renal damage and cardiovascular morbidity/mortality in diabetic patients, 8 in hypertensive individuals, 9 and in general popul...